These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5970147)

  • 1. Investigations of some physio-biochemical properties of ceruloplasmin in schizophrenics and in normal subjects.
    Puzyński S; Kalinowski A
    Nature; 1966 Oct; 212(5060):399-400. PubMed ID: 5970147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the blood serum from subjects with hepatolenticular degeneration on the ceruloplasmin activity in the serum of normal and schizophrenic subjects].
    Puzyński S; Kalinowski A
    Neurol Neurochir Psychiatr Pol; 1966 Aug; 16(8):885-90. PubMed ID: 5969522
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE ACTIVITY OF CERULOPLASMIN IN NEUROLOGIC AND PSYCHIATRIC DISORDERS WITH SPECIAL REFERENCE TO MULTIPLE SCLEROSIS].
    FISCH G
    Confin Neurol; 1964; 24():257-80. PubMed ID: 14154337
    [No Abstract]   [Full Text] [Related]  

  • 4. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 8. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
    [No Abstract]   [Full Text] [Related]  

  • 11. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 12. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-biological considerations on a case of Wilson's disease with normal ceruloplasmin levels].
    REBUCCI GG; TASSINARI CA
    Riv Patol Nerv Ment; 1962 Sep; 83():498-518. PubMed ID: 13973459
    [No Abstract]   [Full Text] [Related]  

  • 15. Low ceruloplasmin in a patient with Niemann-Pick type C disease.
    Connemann BJ; Gahr M; Schmid M; Runz H; Freudenmann RW
    J Clin Neurosci; 2012 Apr; 19(4):620-1. PubMed ID: 22269206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The copper hypothesis of schizophrenia: a review.
    Bowman MB; Lewis MS
    Neurosci Biobehav Rev; 1982; 6(3):321-8. PubMed ID: 7177508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasilets IM; Shavlovskii MM
    Mol Biol; 1971; 5(6):739-42. PubMed ID: 5005463
    [No Abstract]   [Full Text] [Related]  

  • 19. Wilson's disease and the concentration of caeruloplasmin in serum.
    SCHEINBERG IH; STERNLIEB I
    Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
    [No Abstract]   [Full Text] [Related]  

  • 20. Some aspects of the relation of ceruloplasmin to Wilson's disease.
    SCHEINBERG IH; HARRIS RS; MORELL AG; DUBIN D
    Neurology; 1958 Apr; 8(Suppl 1):44-51. PubMed ID: 13541603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.